Why can antigen immunoassays miss early or asymptomatic cases?

Question

Accepted Answer

Antigen Immunoassays Can Miss Early or Asymptomatic Cases Due to Antibody Detection Timelines

Antigen immunoassays may fail to detect early or asymptomatic cases of Covid-19 because they rely on the presence of IgM and IgG antibodies, which typically appear 7 to 14 days after the onset of illness. This means that during the initial stages of infection, when a person might be asymptomatic or just beginning to show mild symptoms, these antibodies have not yet developed sufficiently to be detected by the immunoassay.
Antibody Production Timeline in Immune Response

The body's immune system produces specific antibodies, such as IgM and IgG, in response to the SARS-CoV-2 virus. IgM antibodies are generally the first to appear, indicating a recent infection, followed by IgG antibodies, which signify a more established or past infection. The appearance of these antibodies is a key indicator of the immune system's fight against the virus. However, the immunological process of generating a detectable level of these antibodies takes time, usually within a two-week window following exposure and initial infection.
Limitations Compared to rt-PCR for Early Detection

Reverse transcriptase-Polymerase Chain Reaction (rt-PCR) is considered the gold standard for detecting Covid-19 during the acute phase of the illness, even before symptoms manifest. This method directly identifies the genetic material of the SARS-CoV-2 virus. In contrast, antigen immunoassays, which detect the presence of viral proteins or the body's antibody response, are generally less accurate for early diagnosis. While rt-PCR can identify the virus at very low levels early in the infection, antigen immunoassays are most useful after the onset of symptoms, when viral load or antibody levels are higher.
Role of Immunoassays in Broader Surveillance

Despite their limitations in diagnosing acute or early-stage infections, antibody immunoassays can still play a valuable role in understanding the broader spread of Covid-19 within a community. Their ease of use, lower cost, and rapid results (typically within 20-60 minutes) make them suitable for point-of-care testing. By identifying individuals who have developed antibodies, these tests can help ascertain the extent of community transmission, including cases that were mild or asymptomatic and may have gone undiagnosed by other methods. This information is crucial for public health surveillance and understanding the overall impact of the pandemic.

Reading history

Hide →

This history is cleared when the page is closed.

Why can antigen immunoassays miss early or asymptomatic cases?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends